C0033497||propranolol
C0035372||Rett syndrome
C0035372||Rett Syndrome
C0035372||Rett Syndrome
C2249692||loss-of-function in the epigenetic modulator
C0173924||X-linked methyl-CpG binding protein 2
C0173924||methyl-CpG binding protein 2
C0027765||neurological disorder
C0003467||anxiety
C0025362||mental retardation
C0023015||language
C0751265||learning disabilities
C0038273||repetitive stereotyped hand movements
C1836830||developmental regression
C1397014||imbalance
C0039044||sympathetic
C0030510||parasympathetic nervous system
C0013363||dysautonomia
C0030660||autonomic storms
C0035372||Rett Syndrome
C1254351||beta blocker
C0033497||propranolol
C2267069||sympathetic hyperactivity
C0035372||Rett Syndrome
C0035372||Rett Syndrome
C0422813||clinical picture
C1260922||disordered breathing
C0020578||hyperventilation
C0003578||apnoea
C0014544||epilepsy
C0036439||scoliosis
C1513916||no
C0151878||QT prolongation
C1623258||electrocardiogram
C1623258||electrocardiogram
C1513916||no
C0018798||cardiac abnormalities
C0429087||PR interval
C0488377||QRS duration
C0270549||generalised anxiety disorder
C0009806||constipated
C0176751||percutaneous endoscopic gastrostomy
C0176751||percutaneous endoscopic gastrostomy
C0013363||dysautonomia
C0033497||propranolol
C1269723||physiological parameters
C0018810||heart rate
C1123023||skin
C1326386||transpiration
C0232417||skin temperature increased
C1123023||skin
C1326386||transpiration
C0018810||heart rate
C0033497||propranolol
C1997754||heart rate response
C0033497||propranolol
C0013363||dysautonomia
C0035372||Rett Syndrome
C0013363||dysautonomia
C0035372||Rett Syndrome
C0040808||treatment strategies
C0012634||disorders
C0035372||Rett Syndrome